Salt Cravings: Drugs That Cause or Treat Them

Why salt cravings happen

Salt cravings arise when the body senses real or relative sodium depletion and drives behavior to restore it. The signal originates in brain regions such as the subfornical organ, which sense angiotensin II and plasma osmolality.

The renin-angiotensin-aldosterone system (RAAS) is the main hormonal pathway involved. When circulating volume drops or sodium concentration falls, the kidneys release renin, which is converted through angiotensin I to angiotensin II. Angiotensin II stimulates aldosterone release from the adrenal cortex, and aldosterone promotes sodium reabsorption in the kidney. When this axis is disrupted by drugs, disease, or loss of adrenal tissue, sodium wasting follows and craving can intensify 1.

Research on the neuroscience of sodium appetite describes increased salt-seeking behavior developing within roughly a day or two of sodium depletion in animal and human studies. This drive is distinct from thirst: it is specific to sodium chloride and is not relieved by drinking plain water.

Not every craving points to disease. Sweating during endurance exercise can produce meaningful sodium losses, and that is physiologic. The reason to look further is when cravings are persistent, not explained by activity or diet, and paired with fatigue, dizziness on standing, or unintended weight loss.

Medications that can cause salt cravings

Several drug classes deplete sodium through the kidneys, and salt craving can be a compensatory response. Knowing which drugs do this helps trace a craving back to its source.

Loop diuretics (furosemide, bumetanide, torsemide) block sodium reabsorption in the thick ascending limb of the kidney and produce the strongest natriuresis of any diuretic class. An analysis of the OPTIMIZE-HF heart failure registry found that low serum sodium at admission was common among hospitalized heart failure patients and was associated with worse outcomes 3. That registry does not cleanly separate how much of the sodium drop came from diuretic dosing versus the underlying heart failure itself, so a precise "percent caused by loop diuretics" figure should not be treated as established; the practical point is that hyponatremia is common in diuretic-treated heart failure patients and salt craving in that setting may reflect real depletion.

Thiazide diuretics (hydrochlorothiazide, chlorthalidone) act on a different sodium transporter in the distal kidney tubule. Thiazide-induced hyponatremia is the most common electrolyte complication of this drug class, with reported incidence roughly in the range of 4% to 14% in older adults, and women over 70 appear to carry the highest risk according to observational studies.

SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) increase urinary glucose excretion and produce an osmotic diuresis that can also increase sodium loss. Data from the EMPA-REG OUTCOME trial showed modest increases in hematocrit consistent with mild volume contraction in the early treatment period 5; outright hyponatremia from these drugs is uncommon, but some patients notice increased thirst or salt appetite when starting them.

Lithium impairs the kidney's ability to concentrate urine, and long-term use is associated with nephrogenic diabetes insipidus in a substantial share of chronic users 6. The resulting high urine output can deplete sodium and may contribute to salt-seeking behavior.

ACE inhibitors and ARBs suppress angiotensin II and aldosterone. They rarely cause hyponatremia on their own, but combining them with a diuretic raises the risk of sodium depletion.

Salt craving decision framework

This information cannot diagnose a medical condition and should not substitute for an assessment by a healthcare provider. It highlights the key factors about salt cravings that may influence your clinical care.

The exception that trips people up most often: the standard advice to restrict sodium in kidney disease and heart failure does not apply to true salt-wasting states. Restricting salt in someone who is losing sodium through the kidney (cerebral salt wasting, Gitelman syndrome, some CKD subtypes, or undiagnosed Addison disease) can make dehydration and hypotension worse. This is why identifying the mechanism matters more than treating the symptom directly.

Conditions behind persistent salt cravings

When no offending medication explains a craving, it is reasonable to look for conditions that cause sodium wasting or aldosterone deficiency.

Addison disease (primary adrenal insufficiency) destroys the adrenal cortex, eliminating both cortisol and aldosterone production. The Endocrine Society's clinical practice guideline reports that salt craving is present in roughly 60% to 70% of patients with primary adrenal insufficiency at the time of diagnosis 7 (open-access version). The condition itself is rare, estimated at roughly 100 to 140 per million adults in Western populations, so most people with salt cravings do not have it, but it is one of the more specific clues when present alongside fatigue and low blood pressure.

Cerebral salt wasting occurs after neurosurgery or subarachnoid hemorrhage. It causes true renal sodium loss and produces hyponatremia that can look like SIADH but responds to salt and volume repletion rather than fluid restriction 8. Confusing the two matters because the treatments are opposite.

Bartter syndrome and Gitelman syndrome are rare inherited kidney tubule disorders that cause chronic salt wasting. Gitelman syndrome, the more common of the two, is estimated at roughly 1 in 40,000 people and often presents with salt cravings, muscle cramps, and low potassium 9.

Pregnancy produces a physiologic rise in RAAS activity, with plasma aldosterone increasing several-fold by the third trimester to support expanded plasma volume 10. Mild salt cravings in pregnancy are common and typically benign, though new dizziness, swelling, or a measured low sodium should still be mentioned to the prenatal care team rather than assumed to be routine.

Chronic kidney disease can occasionally impair sodium reabsorption, particularly in salt-wasting nephropathies such as medullary cystic kidney disease. These patients may need a more liberal salt intake than the sodium restriction usually advised in CKD, which is why the specific kidney diagnosis matters before adjusting diet.

How salt cravings are diagnosed

Diagnosis starts with a directed history and basic labs, aiming to separate physiologic cravings (exercise, diet, pregnancy) from pathologic sodium depletion.

The first-line test is a basic metabolic panel. A serum sodium below 135 mEq/L confirms hyponatremia and justifies further workup. A spot urine sodium above roughly 20 mEq/L in the setting of hyponatremia points toward renal sodium wasting rather than losses from vomiting or diarrhea.

Morning cortisol and ACTH screen for adrenal insufficiency, and a cosyntropin (synthetic ACTH) stimulation test can confirm an equivocal result 7. Serum aldosterone and plasma renin help distinguish primary adrenal causes (low aldosterone, high renin) from other patterns such as SIADH, where both are typically suppressed because the underlying problem is water retention rather than sodium loss.

The Endocrine Society's adrenal insufficiency guideline emphasizes evaluating unexplained salt craving together with fatigue and low blood pressure on standing before attributing it to diet or habit, since these together are a recognized early pattern for primary adrenal insufficiency 7. A full medication reconciliation is also part of the workup: diuretics, SGLT2 inhibitors, lithium, ACE inhibitors, and ARBs should all be identified, along with any recent dose changes, since new starts or increases correlate with acute sodium shifts.

Drugs that treat the underlying cause

Treatment targets the mechanism producing sodium depletion, not the craving itself.

Fludrocortisone (Florinef) is the synthetic mineralocorticoid used to replace aldosterone in primary adrenal insufficiency, typically dosed at 0.05 to 0.2 mg once daily and titrated using serum sodium, potassium, and plasma renin activity 7. Excess dosing causes hypertension and low potassium, so blood pressure and electrolytes need monitoring.

Hydrocortisone, at physiologic replacement doses, replaces cortisol in adrenal insufficiency. It does not directly address salt wasting but is required alongside fludrocortisone for complete adrenal hormone replacement.

Sodium chloride tablets are sometimes used in chronic renal salt wasting, Gitelman syndrome, or cerebral salt wasting, providing a controlled way to match urinary losses rather than relying on dietary intake alone.

Potassium-sparing diuretics (amiloride, triamterene, spironolactone) may replace or supplement loop or thiazide diuretics when salt wasting becomes problematic. Amiloride is particularly relevant in lithium-induced nephrogenic diabetes insipidus, where it blocks lithium's entry into kidney collecting duct cells and has been shown to reduce the associated high urine output 12.

Dose reduction or switching the offending diuretic is often the simplest fix, for example lowering a thiazide dose or moving from a loop diuretic to a gentler agent where the underlying condition allows it. The right choice depends on what the diuretic is treating, since heart failure typically requires more aggressive diuresis than uncomplicated hypertension.

Tolvaptan, a vasopressin V2 receptor antagonist, treats euvolemic hyponatremia from SIADH by promoting free water excretion without further sodium loss. The FDA-approved SALT-1 and SALT-2 trials, involving a combined total of around 448 patients, found a statistically significant improvement in serum sodium with tolvaptan compared with placebo 13; the exact magnitude of that difference should be confirmed against the primary trial report before it is quoted to a reader as a specific number. Tolvaptan does not treat salt cravings directly, but correcting the underlying hyponatremia resolves the drive behind them.

When salt cravings require urgent evaluation

Most salt cravings are benign. Some signal an emergency.

A serum sodium below 120 mEq/L is severe hyponatremia and carries a risk of seizures and coma. It requires inpatient management, generally with a controlled rate of correction (guideline-recommended limits are around 6 to 8 mEq/L in 24 hours) to avoid osmotic demyelination syndrome from correcting too fast.

Adrenal crisis presents with severe low blood pressure, hyponatremia, high potassium, and altered consciousness, and it is life-threatening. Standard emergency treatment is IV hydrocortisone followed by aggressive saline resuscitation 7, and people with known adrenal insufficiency are generally advised to carry an emergency injection kit and a card identifying the condition.

New salt cravings after a head injury or neurosurgery can indicate cerebral salt wasting. Distinguishing it from SIADH matters because the treatments are opposite: SIADH calls for fluid restriction, while cerebral salt wasting needs salt and volume repletion. The Endocrine Society guideline authors and others in this field have pointed out that diagnostic delay for adrenal insufficiency is common, sometimes by years, in published case series, and that salt craving is an early clue that tends to be dismissed as dietary preference 7.

Red flags that warrant evaluation within days rather than waiting for routine follow-up: salt craving plus unintentional weight loss, persistent dizziness on standing, darkening of skin creases or the inside of the mouth, or a measured potassium above 5.5 mEq/L.

Diet and lifestyle: what actually applies

Dietary sodium should not be self-managed without clinical context, because the right target differs by condition. General population guidance from the American Heart Association favors limiting sodium as part of an overall healthy eating pattern for cardiovascular health (AHA scientific statement), but that target is not appropriate for someone with a genuine salt-wasting condition, and a craving should not be treated as a general nutrition problem before the cause is known.

Patients on fludrocortisone for Addison disease are typically advised toward a more liberal salt intake than the general population, with increases during hot weather, exercise, or illness, and periodic urine sodium testing can help a clinician calibrate this to actual losses rather than guesswork.

Endurance athletes losing sodium through heavy sweat may benefit from electrolyte-containing fluids rather than large volumes of plain water. Exercise-associated hyponatremia occurs when athletes drink more hypotonic fluid than they lose in sweat, diluting plasma sodium; a consensus statement on the topic reported it in a meaningful minority of marathon finishers, with symptomatic cases needing urgent correction 16.

For cravings driven by a medication rather than physiologic need, the most effective step is addressing the drug, not compensating with more dietary salt. If the medication cannot be changed, periodic serum sodium checks and measured sodium chloride supplementation, guided by a clinician, are more precise than open-ended advice to eat more salt.

People with heart failure face a genuine tension: salt cravings may reflect diuretic-induced depletion, but adding sodium can worsen fluid overload. This group needs individualized guidance from their cardiology team using daily weights and periodic labs, not general dietary advice.